Innovative Industrial Properties, Inc. filings document the disclosure record of a Maryland REIT that owns specialized industrial properties and life science real estate through an UPREIT structure. Periodic and current reports cover operating results, supplemental financial information, rental revenue, portfolio leasing activity, tenant-related matters, and the economics of its cannabis and life science property portfolios.
The company’s SEC filings also describe secured term loans, promissory notes, unsecured senior notes, preferred stock, share repurchase authorization, dividend and distribution disclosures, and material definitive agreements. Proxy materials cover annual meeting matters, board composition, executive compensation, stockholder voting items and governance practices.
Innovative Industrial Properties Inc. (IIPR) is the issuer in BlackRock, Inc.’s amended beneficial-ownership report. BlackRock reported 4,884,245 common shares, or 17.7% of the class, as beneficially owned as of September 30, 2026. It reported sole voting power over 4,782,329 shares and sole dispositive power over 4,884,245 shares. The report covers securities attributed to certain BlackRock business units and excludes any holdings of other business units disaggregated under the cited SEC release. It identifies iShares Core S&P Small-Cap ETF as having an interest in more than 5% of IIPR’s outstanding common stock.
Innovative Industrial Properties, Inc. (IIPR), through its operating partnership, IIP Operating Partnership, LP, amended its secured revolving credit facility, extending its maturity from October 23, 2026, to January 21, 2027. East West Bank acted as agent and a lender, alongside the other lenders.
The operating partnership paid the lenders an extension fee. The amendment leaves aggregate commitments, the interest rate, the borrowing base and covenants unchanged. Aggregate principal outstanding under the facility was $62.5 million as of October 21, 2026.
Innovative Industrial Properties, Inc. (IIPR) agreed to issue and sell 2,000,000 shares of its 9.25% Series B Cumulative Redeemable Preferred Stock at a public offering price of $25.00 per share. The underwriters may purchase up to 300,000 additional shares under a 30-day option on the same terms. The agreement is with the company’s operating partnership and Stifel, Nicolaus & Company, Incorporated, as representative of the underwriters. The offering is expected to close on or about October 19, 2026, subject to customary closing conditions. The company expects approximately $48.4 million in net proceeds after the underwriting discount and before estimated expenses, assuming the option is not exercised.
On October 13, 2026, the company designated 2,300,000 authorized preferred shares as Series B; the designation became effective upon filing. The Series B shares have a $25.00-per-share liquidation preference. Upon issuance, the company’s ability to make distributions with respect to, or redeem, purchase or acquire, or make liquidation payments on stock ranking junior to or on parity with Series B will be subject to certain restrictions if it does not declare Series B distributions during any distribution period.
Innovative Industrial Properties (IIPR) Executive Chairman Alan D. Gold purchased 40,000 shares of its 9.25% Series B Cumulative Redeemable Preferred Stock on October 8, 2026, at $25 per share. The purchase was made in connection with the company’s public offering at the offering price pursuant to a Form S-3 registration statement. Gold directly held 40,000 shares following the purchase; no Rule 10b5-1 plan is reported.
Innovative Industrial Properties, Inc. (IIPR) is offering 2,000,000 shares of 9.25% Series B cumulative redeemable preferred stock at $25.00 per share. Estimated net proceeds are approximately $48.1 million after the underwriting discount and estimated offering expenses. Underwriters may purchase up to 300,000 additional shares within 30 days solely to cover over-allotments; estimated net proceeds would be approximately $55.4 million if exercised in full. Proceeds are intended to fund all or part of the remaining unfunded commitment under the Alewife Mezzanine Loan; any remainder may support other investments, working capital or general corporate purposes.
The shares carry cumulative cash dividends at 9.25% of the $25.00 liquidation preference, equal to $2.3125 annually per share and payable quarterly; the first payment is scheduled for January 15, 2027, at $0.5524 per share. They rank on parity with Series A preferred stock and ahead of common stock for dividends and liquidation, but below debt. They have no stated maturity and generally cannot be redeemed before October 19, 2031. IIPR intends to apply for NYSE listing under IIPR Pr B; if approved, trading is expected to begin within 30 days after initial delivery.
Innovative Industrial Properties, Inc. (IIPR) is conducting a preliminary offering of Series B Cumulative Redeemable Preferred Stock with a $25.00 per-share liquidation preference. The shares rank senior to common stock and on parity with Series A preferred stock for dividend and liquidation rights, but junior to debt in right of payment. They have no stated maturity and are not subject to mandatory redemption or a sinking fund. IIPR intends to apply to list the shares on the NYSE under IIPR Pr B; if approved, trading is expected within 30 days after initial delivery.
On September 28, 2026, wholly owned subsidiary IIP Life Science Investments II LLC funded an approximately $111.0 million initial advance under the Alewife Mezzanine Loan. The proceeds repaid an existing $85.0 million bridge loan, plus accrued interest, fees, a minimum return payment and other amounts due. The loan’s Applicable Rate is the greater of 14% per annum or the applicable benchmark—initially one-month Term Secured Overnight Financing Rate—plus 9.0% per annum. Its maturity is February 9, 2028, with a one-year extension option subject to conditions. Net proceeds from the preferred offering are intended to fund all or part of the remaining unfunded loan commitment; any remainder is intended for investments consistent with IIPR’s strategy, working capital or other general corporate purposes.
Innovative Industrial Properties, Inc. (IIPR), through wholly owned subsidiary IIP Life Science Investments II LLC, agreed to provide a $245 million mezzanine loan commitment to IQHQ affiliates for Alewife Park, a life science campus in Cambridge, Massachusetts. At closing on September 28, 2026, the subsidiary funded approximately $111 million to repay the borrower’s $85 million bridge loan and related amounts. A further $134 million is expected to be funded through the fourth quarter of 2027 as amounts are drawn and funding conditions are satisfied.
The loan is expected to yield approximately 15.8% over its term, subject to a 14% floor, and matures February 9, 2028. A second one-year extension is available subject to conditions, including extension of the senior mortgage loan. The loan is secured by pledges of equity interests in entities owning the property, with completion, environmental and recourse guaranties from IQHQ, LP.
IIP may also purchase all or part of the other mezzanine lender’s notes, up to approximately $155 million in maximum principal amount, subject to conditions. IIP Life Science II’s right of first offer to purchase, finance or refinance the property becomes effective when total Note B funding equals or exceeds $155 million; until then, lenders’ right of first negotiation remains in effect.
INNOVATIVE INDUSTRIAL PROPERTIES INC (symbol: IIPR) is the issuer of record for a Form 8-K filing submitted to the SEC.
INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) director Scott Shoemaker reported selling 611 shares of common stock on September 15, 2026 at $56.36 per share, leaving 2,000 common shares held directly. He also reports multiple series of restricted stock units, each representing the right to receive one share of common stock upon vesting under the company’s Nonqualified Deferred Compensation Plan.
INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) is reported to have 2,862,469 shares of its common stock beneficially owned by Vanguard Portfolio Management and certain affiliates, representing 10.38% of the class as of August 31, 2026. Vanguard reports sole voting power over 12,092 shares and sole dispositive power over all 2,862,469 shares, with no shared voting or dispositive power.
The position reflects securities held by Vanguard Portfolio Management LLC, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC, and related Vanguard funds and managed accounts, and no other single person's interest in the reported securities exceeds 5%.